BERACTANT

1 FDA products 1 manufacturers ENDOTRACHEAL

BERACTANT is an active ingredient listed in 1 FDA drug label records from 1 manufacturers taken by endotracheal route marketed mainly as human prescription drug products.

About BERACTANT

BERACTANT appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from AbbVie Inc.. In this ingredient’s product set, the most common route of administration is endotracheal. Approved labelling for these products most frequently references: usage survanta, treatment rescue, respiratory distress, syndrome rds, hyaline membrane, disease premature. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.

How it is supplied

Dosage formProductsRouteProducts
— — ENDOTRACHEAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

Main manufacturers

ManufacturerProductsMarketing type
AbbVie Inc. 1 HUMAN PRESCRIPTION DRUG

FDA drug products containing BERACTANT

Brand nameManufacturerTypeRouteDosage form
Survanta AbbVie Inc. HUMAN PRESCRIPTION DRUG ENDOTRACHEAL

Frequently asked questions

How many FDA drug products contain BERACTANT?
1 FDA drug label records list BERACTANT as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.

Which companies make BERACTANT products?
The manufacturers with the most BERACTANT label records are AbbVie Inc.. Generic and brand versions may be produced by different companies.

Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.

This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.